Immitra Bio GmbH
Biotechnology · Plan-les-Ouates, Geneva
Immitra Bio GmbH is a Swiss biotechnology company based in Plan-les-Ouates, Canton of Geneva, listed in the Swiss commercial register since 2025 (UID CHE-383.430.919).
Board members & signatories
- Amir Taheri Ghahfarokhi — Geschäftsführer
- Jan Nelis — Gesellschafter
- Jacob Corn — Gesellschafter
Registered purpose
la recherche, le développement et la commercialisation de thérapies cellulaires et géniques destinées au traitement de diverses maladies. La société peut créer des succursales en Allemagne et à l'étranger et participer à d'autres entreprises en Allemagne et à l'étranger. La société peut exercer toutes les activités qui sont en rapport avec son objet et qui sont susceptibles de favoriser ou de faci…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Immitra Bio does
OFFERING
Immitra Bio GmbH is developing an in-vivo gene editing platform aimed at treating rare genetic diseases. Their approach focuses on a single, off-the-shelf injection that aims to replace traditional stem cell therapies, which are often toxic and complex. The company is initially targeting severe inherited red blood cell disorders with its innovative treatment.
Unlock the full analysis →Similar companies
- CRISPR Therapeutics AG — Biotechnology · Zug
- FimmCyte AG — Biotechnology · Basel
- Engimmune Therapeutics AG — Biotechnology · Allschwil
- Immunocore GmbH — Biotechnology · Rotkreuz
- Enable Biotech AG — Contract Development & Manufacturing (CDMO) · Zug
- Biogen International GmbH — Biotechnology · Baar
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime